IMDX vs ABOS
Comparison between Insight Molecular Diagnostics Inc (IMDX, Company) and Acumen Pharmaceuticals Inc (ABOS, Company).
Both IMDX and ABOS are from the Healthcare sector.
5-Year PerformanceABOS has outperformed IMDX, delivering a return of -31.6% compared to -44.8%
IMDX vs ABOS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
IMDX vs ABOS - Historical Returns
Returns include dividend reinvestment.
IMDX vs ABOS - Annual Returns (2016 - 2026)
Returns include dividend reinvestment.
| Year | IMDX | ABOS |
|---|---|---|
| 2026 | -30.17% | +10.89% |
| 2025 | +221.89% | +14.05% |
| 2024 | -27.88% | -59.34% |
| 2023 | -63.77% | -27.00% |
| 2022 | -85.74% | -19.76% |
| 2021 | -9.21% | -66.37% |
| 2020 | +7.17% | N/A |
| 2019 | +53.06% | N/A |
| 2018 | -70.00% | N/A |
| 2017 | -31.11% | N/A |
| 2016 | -21.67% | N/A |
IMDX vs ABOS Drawdown Comparison
The maximum drawdown for IMDX was -99.03%, occurring on Jan 22, 2025. This drawdown has not yet recovered.
The maximum drawdown for ABOS was -95.56%, occurring on Apr 17, 2025. This drawdown has not yet recovered.
The current IMDX drawdown is -97.53%. The current ABOS drawdown is -88.95%.
| Rank | IMDX | ABOS |
|---|---|---|
| #1 | -99.03% Jan 5, 2016 - Jan 22, 2025 | -95.56% Jul 2, 2021 - Apr 17, 2025 |
Correlation
Correlation between IMDX and ABOS is 0.87 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks